Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Transthyretin Amyloidosis Treatment Market 2025 – By Type (Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM), Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)), By Drug (Tafamidis, Patisiran, Inotersen, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2034

Name: Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Report Price : $4490.00 | Pages : 278 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Transthyretin Amyloidosis Treatment Market Definition

Transthyretin amyloidosis (ATTR) treatment refers to the medical treatments aimed at managing transthyretin amyloidosis, a progressive, life-threatening disease resulting from misfolded transthyretin proteins that form amyloid deposits in tissues. The condition arises due to familial or spontaneous mutations that destabilize transthyretin protein, causing aggregation and deposition of fibers in various tissues. This rare condition primarily affects the peripheral nerves, heart and other organs, with the two main forms being polyneuropathy (nerve damage) and cardiomyopathy (heart muscle disease).

The ATTR treatment market consists of sales by entities (organizations, sole traders and partnerships) of ATTR treatment drugs that are essential for controlling the disease's progression, managing symptoms and improving the quality of life for affected patients, as untreated cases can lead to significant morbidity and reduced life expectancy.

Book your 30 minutes free consultation with our research experts

Transthyretin Amyloidosis Treatment Market Size

The global transthyretin amyloidosis treatment market reached a value of nearly $4,250.83 million in 2023, having grown at a compound annual growth rate (CAGR) of 95.43% since 2018. The market is expected to grow from $4,250.83 million in 2023 to $6,289.03 million in 2028 at a rate of 8.15%. The market is then expected to grow at a CAGR of 8.91% from 2028 and reach $9,635.77 million in 2033.

Growth in the historic period resulted from increased healthcare expenditure, increasing adoption of personalized medicine, enhanced healthcare infrastructure and increasing prevalence of transthyretin amyloidosis cases. Factor that negatively affected growth in the historic period was limited awareness.

Going forward, increasing aging population, increasing regulatory approvals, increasing e-commerce growth, strong economic growth in emerging markets and favorable government initiatives will drive the growth. Factor that could hinder the growth of the transthyretin amyloidosis treatment market in the future include high cost of treatment.

Transthyretin Amyloidosis Treatment Market Drivers

The key drivers of the transthyretin amyloidosis treatment market include:

Increasing Aging Population

The increasing size of the aging population is expected to propel the growth of the transthyretin amyloidosis (ATTR) treatment market in the forecast period. The aging population is expected to undergo more frequent medical check-ups and diagnostic procedures, leading to a higher rate of ATTR detection and diagnosis. As awareness of the condition increases among both healthcare professionals and patients, the likelihood of earlier diagnosis rises, prompting a greater demand for treatment options. For instance, according to the United Nations Department of Economic and Social Affairs, a US-based intergovernmental agency, the global population of individuals aged 65 years or older is expected to increase dramatically, more than doubling from 761 million in 2021 to 1.6 billion by 2050. In 2021, one out of every ten individuals worldwide were 65 or older. By 2050, projections indicate that this age group will comprise one out of every six people globally. Additionally, in October 2023, according to the United Nations Population Fund, a US-based agency aimed at improving reproductive and maternal health worldwide, the demographic of individuals aged 60 and above is expected to rise from 149 million in 2022 to 347 million by 2050. India's elderly population is forecast to double by 2050, surpassing the number of children in the country. Therefore, the increasing aging population will drive the growth of the ATTR treatment market.

Transthyretin Amyloidosis Treatment Market Restraints

The key restraints on the transthyretin amyloidosis treatment market include:

High Cost of Treatment

High cost of treatment is expected to restrain the growth of the ATTR treatment market. The high cost of ATTR treatments imposes a significant financial strain on healthcare systems, especially in regions with publicly funded healthcare or limited budgets for rare diseases. This could lead to delayed access or restricted availability of treatments, thereby slowing market growth. Treatment for transthyretin amyloidosis involves a combination of medications, ongoing monitoring and sometimes hospitalization, making it quite complex and costly. For patients needing advanced therapies like tafamidis or diflunisal, the annual treatment expenses can exceed $100,000. Tafamidis, in particular, is known for its high price, which can reach around $225,000 per year, making it one of the most expensive cardiovascular drugs available. Therefore, the high cost of treatment will limit the growth of the ATTR treatment market.

Transthyretin Amyloidosis Treatment Market Trends

Major trends shaping the transthyretin amyloidosis treatment market include:

Advancing Treatment Options For Amyloidosis With Novel Therapeutic Antibody

Major companies operating in the transthyretin amyloidosis treatment market are advancing treatment options for amyloidosis with novel therapeutic antibodies. The objective is to address the treatment gap for the disease by offering essential therapies to patients with limited treatment options. For instance, in May 2024, AstraZeneca, a UK-based pharmaceutical company, through its Rare Disease subsidiary, Alexion, initiated research focused on cardiomyopathy associated with transthyretin amyloidosis (ATTR). This effort includes the launch of the Phase 3 DepleTTR-CM study for ALXN2220, an investigational antibody designed to target cardiac amyloid deposits—harmful protein buildups that can cause serious cardiac complications, including progressive heart failure if left untreated. By reducing these deposits, ALXN2220 aims to mitigate symptoms and slow the progression of ATTR cardiomyopathy, a severe condition that can greatly affect patients’ quality of life. Additionally, in July 2021, Novo Nordisk is a Denmark-based pharmaceutical company acquired Prothena Corporation's clinical-stage antibody, PRX004, along with its broader program for the treatment of ATTR amyloidosis, a severe and rare disease marked by the accumulation of misfolded proteins in organs, particularly the heart, for $1.2 billion. This acquisition is intended to strengthen Novo Nordisk's portfolio in innovative cardiovascular treatments by utilizing Prothena's amyloidosis expertise to address substantial unmet medical needs in this sector. Prothena Corporation is an Ireland-based company that provides treatment for transthyretin amyloidosis.

Opportunities And Recommendations In The Transthyretin Amyloidosis Treatment Market

Opportunities – The top opportunities in the transthyretin amyloidosis treatment market segmented by type will arise in the transthyretin amyloidosis with cardiomyopathy (ATTR-CM) segment, which will gain $1,566.37 million of global annual sales by 2028. The top opportunities in the transthyretin amyloidosis treatment market segmented by drug will arise in the tafamidis segment, which will gain $1,536.00 million of global annual sales by 2028. The top opportunities in the transthyretin amyloidosis treatment market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $1,545.80 million of global annual sales by 2028. The transthyretin amyloidosis treatment market size will gain the most in the USA at $679.70 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the transthyretin amyloidosis treatment companies to focus on advancing novel therapeutics for transthyretin amyloidosis, focus on ATTR-PN for market growth, focus on the other drugs segment for growth, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, focus on hospital pharmacies for market growth and focus on aging population worldwide.

Transthyretin Amyloidosis Treatment Market Segmentation

The transthyretin amyloidosis treatment market is segmented by type, by drug and by distribution channels.

By Type –
The transthyretin amyloidosis treatment market is segmented by type into:

a) Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
b) Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)

The transthyretin amyloidosis with cardiomyopathy (ATTR-CM) market was the largest segment of the transthyretin amyloidosis treatment market segmented by type, accounting for 81.29% or $3,455.48 million of the total in 2023. Going forward, the transthyretin amyloidosis with polyneuropathy (ATTR-PN) segment is expected to be the fastest growing segment in the transthyretin amyloidosis treatment market segmented by type, at a CAGR of 9.76% during 2023-2028.

By Drug –
The transthyretin amyloidosis treatment market is segmented by drug into:

a) Tafamidis
b) Patisiran
c) Inotersen
d) Other Drugs

The tafamidis market was the largest segment of the transthyretin amyloidosis treatment market segmented by drug, accounting for 80.82% or $3,435.49 million of the total in 2023. Going forward, the other drugs segment is expected to be the fastest growing segment in the transthyretin amyloidosis treatment market segmented by drug, at a CAGR of 11.69% during 2023-2028.

By Distribution Channel –
The transthyretin amyloidosis treatment market is segmented by distribution channel into:

a) Hospital Pharmacies
b) Retail Pharmacies
c) Online Pharmacies

The hospital pharmacies market was the largest segment of the transthyretin amyloidosis treatment market segmented by distribution channel, accounting for 77.47% or $3,293.31 million of the total in 2023. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the transthyretin amyloidosis treatment market segmented by distribution channel, at a CAGR of 9.39% during 2023-2028.

By Geography - The transthyretin amyloidosis treatment market is segmented by geography into:

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA
• Canada

• Brazil

• France
• Germany
• UK
• Italy
• Spain

• Russia

North America was the largest region in the transthyretin amyloidosis treatment market, accounting for 55.89% or $2,375.65 million of the total in 2023. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the transthyretin amyloidosis treatment market will be South America and Middle East where growth will be at CAGRs of 55.78% and 49.14% respectively. These will be followed by Africa and Asia Pacific where the markets are expected to grow at CAGRs of 36.26% and 20.52% respectively.

Transthyretin Amyloidosis Treatment Market Competitive Landscape

Major Competitors are:

Pfizer Inc.

Alnylam Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

BridgeBio Pharma, Inc.

Intellia Therapeutics Inc.

Other Competitors Include:

AstraZeneca

Novo Nordisk A/S

PTC Therapeutics Inc.

Bristol-Myers Squibb Company

Abbvie Inc.

SOM Biotech

Prothena Biosciences

AstraZeneca

Johnson & Johnson

Bausch Health Companies Inc.

Takeda Pharmaceuticals

ONPATTRO

Asprius Lifesciences

Alexion Pharmaceuticals

Prothena Corporation

Sanofi

Bayer

Chiesi Farmaceutici

Regeneron Pharmaceuticals

MedLife S.A.

Pharmstandard

Generium

Attralus, Inc

Ionis Pharmaceuticals

Sorrento Therapeutics Inc.

Ionis Pharmaceuticals

GSK South Africa

1 Executive Summary

1.1 Transthyretin Amyloidosis Treatment – Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition

6.2 Summary

6.3 Transthyretin Amyloidosis Treatment Market Definition And Segmentations

6.4 Market Segmentation By Type

6.4.1 Transthyretin Amyloidosis With Polyneuropathy

6.4.2 Transthyretin Amyloidosis With Cardiomyopathy

6.5 Market Segmentation By Drug

6.5.1 Tafamidis

6.5.2 Patisiran

6.5.3 Inotersen

6.5.4 Other Drugs

6.6 Market Segmentation By Distribution Channel

6.6.1 Hospital Pharmacies

6.6.2 Retail Pharmacies

6.6.3 Online Pharmacies

7 Major Market Trends

7.1 Advancing Treatment Options For Amyloidosis With Novel Therapeutic Antibody

8 Transthyretin Amyloidosis Treatment Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Transthyretin Amyloidosis Treatment Market

8.2 Impact Of The War In Ukraine On The Transthyretin Amyloidosis Treatment Market

8.3 Impact Of High Inflation On The Transthyretin Amyloidosis Treatment Market

9 Global Market Size and Growth

9.1 Market Size

9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

9.2.1 Market Drivers 2018 – 2023

9.2.2 Market Restraints 2018 – 2023

9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

9.3.1 Market Drivers 2023 – 2028

9.3.2 Market Restraints 2023 – 2028

10 Global Transthyretin Amyloidosis Treatment Market Segmentation

10.1 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.2 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.3 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

11 Transthyretin Amyloidosis Treatment Market, Regional and Country Analysis

11.1 Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

11.2 Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary

12.2 Market Overview

12.2.1 Region Information

12.2.2 Market Information

12.2.3 Background Information

12.2.4 Government Initiatives

12.2.5 Regulations

12.2.6 Regulatory Bodies

12.2.7 Major Associations

12.2.8 Taxes Levied

12.2.9 Corporate Tax Structure

12.2.10 Investments

12.2.11 Major Companies

12.3 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.4 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.5 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.6 China Market

12.7 Summary

12.8 Market Overview

12.8.1 Country Information

12.8.2 Market Information

12.8.3 Background Information

12.8.4 Government Initiatives

12.8.5 Regulations

12.8.6 Regulatory Bodies

12.8.7 Major Associations

12.8.8 Taxes Levied

12.8.9 Corporate Tax Structure

12.8.10 Major Companies

12.9 China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.10 China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.11 China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.12 India Market

12.13 India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.14 India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.15 India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.16 Japan Market

12.17 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.18 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.19 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.20 Australia Market

12.21 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.22 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.23 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.24 Indonesia Market

12.25 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.26 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.27 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.28 South Korea Market

12.29 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.30 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.31 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary

13.2 Market Overview

13.2.1 Region Information

13.2.2 Market Information

13.2.3 Background Information

13.2.4 Government Initiatives

13.2.5 Regulations

13.2.6 Regulatory Bodies

13.2.7 Major Associations

13.2.8 Taxes Levied

13.2.9 Corporate tax structure

13.2.10 Investments

13.2.11 Major Companies

13.3 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.4 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.5 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.6 Western Europe Transthyretin Amyloidosis Treatment Market: Country Analysis

13.7 UK Market

13.8 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.9 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.10 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.11 Germany Market

13.12 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.13 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.14 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.15 France Market

13.16 France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.17 France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.18 France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.19 Italy Market

13.20 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.21 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.22 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.23 Spain Market

13.24 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.25 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.26 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary

14.2 Market Overview

14.2.1 Region Information

14.2.2 Market Information

14.2.3 Background Information

14.2.4 Government Initiatives

14.2.5 Regulations

14.2.6 Regulatory Bodies

14.2.7 Major Associations

14.2.8 Taxes Levied

14.2.9 Corporate Tax Structure

14.2.10 Investments

14.2.11 Major companies

14.3 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.4 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.5 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.6 Eastern Europe Transthyretin Amyloidosis Treatment Market: Country Analysis

14.7 Russia Market

14.8 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.9 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.10 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary

15.2 Market Overview

15.2.1 Region Information

15.2.2 Market Information

15.2.3 Background Information

15.2.4 Government Initiatives

15.2.5 Regulations

15.2.6 Regulatory Bodies

15.2.7 Major Associations

15.2.8 Taxes Levied

15.2.9 Corporate Tax Structure

15.2.10 Investments

15.2.11 Major Companies

15.3 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.4 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.5 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.6 North America Transthyretin Amyloidosis Treatment Market: Country Analysis

15.7 USA Market

15.8 Summary

15.9 Market Overview

15.9.1 Country Information

15.9.2 Market Information

15.9.3 Background Information

15.9.4 Government Initiatives

15.9.5 Regulations

15.9.6 Regulatory Bodies

15.9.7 Major Associations

15.9.8 Taxes Levied

15.9.9 Corporate Tax Structure

15.9.10 Investments

15.9.11 Major Companies

15.10 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.11 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.12 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.13 Canada Market

15.14 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.15 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.16 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary

16.2 Market Overview

16.2.1 Region Information

16.2.2 Market Information

16.2.3 Background Information

16.2.4 Government Initiatives

16.2.5 Regulations

16.2.6 Regulatory Bodies

16.2.7 Major Associations

16.2.8 Taxes Levied

16.2.9 Corporate Tax Structure

16.2.10 Investments

16.2.11 Major Companies

16.3 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.4 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.5 South America Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.6 South America Transthyretin Amyloidosis Treatment Market: Country Analysis

16.7 Brazil Market

16.8 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.9 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.10 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary

17.2 Market Overview

17.2.1 Region Information

17.2.2 Market Information

17.2.3 Background Information

17.2.4 Government Initiatives

17.2.5 Regulations

17.2.6 Regulatory Bodies

17.2.7 Major Associations

17.2.8 Taxes Levied

17.2.9 Corporate Tax Structure

17.2.10 Major Companies

17.3 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17.4 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17.5 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary

18.2 Market Overview

18.2.1 Region Information

18.2.2 Market Information

18.2.3 Background Information

18.2.4 Government Initiatives

18.2.5 Regulations

18.2.6 Regulatory Bodies

18.2.7 Major Associations

18.2.8 Taxes Levied

18.2.9 Major Companies

18.3 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18.4 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18.5 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles

19.2 Pfizer Inc

19.2.1 Company Overview

19.2.2 Products And Services

19.2.3 Business Strategy

19.2.4 Financial Overview

19.3 Alnylam Pharmaceuticals, Inc

19.3.1 Company Overview

19.3.2 Products And Services

19.3.3 Business Strategy

19.3.4 Financial Overview

19.4 Ionis Pharmaceuticals, Inc

19.4.1 Company Overview

19.4.2 Products And Services

19.4.3 Business Strategy

19.4.4 Financial Overview

19.5 BridgeBio Pharma, Inc

19.5.1 Company Overview

19.5.2 Products And Services

19.5.3 Business Strategy

19.6 Intellia Therapeutics Inc

19.6.1 Company Overview

19.6.2 Products And Services

19.6.3 Business Strategy

20 Other Major And Innovative Companies

20.1 AstraZeneca

20.1.1 Company Overview

20.1.2 Products And Services

20.2 Novo Nordisk A/S

20.2.1 Company Overview

20.2.2 Products And Services

20.3 PTC Therapeutics Inc.

20.3.1 Company Overview

20.3.2 Products And Services

20.4 Bristol-Myers Squibb Company

20.4.1 Company Overview

20.4.2 Products And Services

20.5 Abbvie Inc.

20.5.1 Company Overview

20.5.2 Products And Services

20.6 SOM Biotech

20.6.1 Company Overview

20.6.2 Products And Services

20.7 Corino Therapeutics Inc.

20.7.1 Company Overview

20.7.2 1.7.2 Products And Services

20.8 Acrotech Biopharma Inc.

20.8.1 Company Overview

20.8.2 Products And Services

20.9 Neurimmune AG

20.9.1 Company Overview

20.9.2 Products And Services

20.10 Sorrento Therapeutics, Inc.

20.10.1 Company Overview

20.10.2 Products And Services

20.11 Oncopeptides AB

20.11.1 Company Overview

20.11.2 Products And Services

20.12 Takeda Pharmaceutical Company Limited

20.12.1 Company Overview

20.12.2 Products And Services

20.13 Astellas Pharma, Inc.

20.13.1 Company Overview

20.13.2 Products And Services

20.14 GSK plc

20.14.1 Company Overview

20.14.2 Products And Services

20.15 Bausch Health Company

20.15.1 Company Overview

20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Astellas Pharma Acquired Polyphor International

23.2 AstraZeneca Acquired Caelum Biosciences

23.3 Novo Nordisk Acquired Prothena Corporation

24 Opportunities And Strategies

24.1 Global Transthyretin Amyloidosis Treatment Market In 2028 – Countries Offering Most New Opportunities

24.2 Global Transthyretin Amyloidosis Treatment Market In 2028 – Segments Offering Most New Opportunities

24.3 Global Transthyretin Amyloidosis Treatment Market In 2028 – Growth Strategies

24.3.1 Market Trend Based Strategies

24.3.2 Competitor Strategies

25 Transthyretin Amyloidosis Treatment Market, Conclusions And Recommendations

25.1 Conclusions

25.2 Recommendations

25.2.1 Product

25.2.2 Place

25.2.3 Price

25.2.4 Promotion

25.2.5 People

26 Appendix

26.1 Geographies Covered

26.2 Market Data Sources

26.3 Research Methodology

26.4 Currencies

26.5 The Business Research Company

26.6 Copyright and Disclaimer

List Of Tables

Table 1: Global Transthyretin Amyloidosis Treatment Market, Historic, 2018 – 2023, $ Million

Table 2: Global Transthyretin Amyloidosis Treatment Market, Forecast, 2023 – 2028, 2033F, $ Million

Table 3: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 4: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 5: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 6: Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 7: Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 8: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $

Table 9: Asia-Pacific Population, By Country, 2018-2028, Millions

Table 10: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 11: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 12: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 13: China GDP Per Capita, 2018-2023, $

Table 14: China Population, 2018-2028, Millions

Table 15: China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 16: China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 17: China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 18: India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 19: India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 20: India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 21: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 22: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 23: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 24: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 25: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 26: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 27: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 28: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 29: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 30: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 31: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 32: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $

Table 34: Western Europe Population, By Country, 2018-2028, Millions

Table 35: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 36: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 37: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 38: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 39: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 40: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 41: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 42: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 43: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 44: France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 45: France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 46: France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 47: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 48: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 49: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 50: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 51: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 52: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 53: Eastern Europe GDP Per Capita, By Country, 2018-2023, $

Table 54: Eastern Europe Population, By Country, 2018-2028, Millions

Table 55: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 56: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 57: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 58: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 59: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 60: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 61: North America GDP Per Capita, By Country, 2018-2023, $

Table 62: North America Population, By Country, 2018-2028, Millions

Table 63: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 64: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 65: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 66: USA GDP Per Capita, 2018-2023, $

Table 67: USA Population, 2018-2028, Millions

Table 68: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 69: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 70: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 71: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 72: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 73: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 74: South America GDP Per Capita, By Country, 2018-2023, $

Table 75: South America Population, By Country, 2018-2028, Millions

Table 76: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 77: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 78: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 79: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 80: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 81: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 82: Middle East GDP Per Capita, By Country, 2018-2023, $

Table 83: Middle East Population, By Country, 2018-2028, Millions

Table 84: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 85: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 86: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 87: Africa GDP Per Capita, By Country, 2018-2023, $

Table 88: Africa Population, By Country, 2018-2028, Millions

Table 89: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 90: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 91: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 92: Global Transthyretin Amyloidosis Treatment Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)

Table 93: Pfizer Inc – Financial Overview, 2019 – 2023, $Billion

Table 94: Alnylam Pharmaceuticals Inc – Financial Overview, 2019 – 2023, $Billion

Table 95: Ionis Pharmaceuticals, Inc – Financial Overview, 2019 – 2023, $Billion

Table 96: Transthyretin Amyloidosis Treatment Market, Competitive Benchmarking (In USD Millions)

Table 97: Transthyretin Amyloidosis Treatment Market, Competitive Dashboard

Table 98: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), 2023 – 2028, By Country

Table 99: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), Segmentation By Type, 2023 – 2028

Table 100: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), Segmentation By Drug, 2023 – 2028

Table 101: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), Segmentation By Distribution Channel, 2023 – 2028

Table 102: Transthyretin Amyloidosis Treatment Market Data Sources

List Of Figures

Figure 1: Global Transthyretin Amyloidosis Treatment Market Segmentation By Type

Figure 2: Global Transthyretin Amyloidosis Treatment Market Segmentation By Drug

Figure 3: Global Transthyretin Amyloidosis Treatment Market Segmentation By Distribution Channel

Figure 4: Global Transthyretin Amyloidosis Treatment Market, Historic, 2018 – 2023, $ Million

Figure 5: Global Transthyretin Amyloidosis Treatment Market, Forecast, 2023 – 2028, 2033F, $ Million

Figure 6: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 7: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 8: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 9: Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 10: Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 11: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 12: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 13: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 14: China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 15: China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 16: China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 17: India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 18: India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 19: India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 20: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 21: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 22: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 23: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 24: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 25: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 26: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 27: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 28: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 29: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 30: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 31: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 32: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 33: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 34: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 35: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 36: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 37: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 38: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 39: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 40: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 41: France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 42: France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 43: France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 44: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 45: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 46: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 47: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 48: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 49: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 50: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 51: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 52: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 53: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 54: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 55: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 56: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 57: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 58: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 59: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 60: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 61: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 62: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 63: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 64: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 65: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 66: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 67: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 68: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 69: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 70: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 71: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 72: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 73: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 74: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 75: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 76: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 77: Global Transthyretin Amyloidosis Treatment Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)

Figure 78: Pfizer Inc – Financial Overview, 2019 – 2023, $ Billion

Figure 79: Alnylam Pharmaceuticals Inc – Financial Overview, 2019 – 2023, $ Billion

Figure 80: Ionis Pharmaceuticals, Inc – Financial Overview, 2019 – 2023, $ Billion

Figure 81: Geographic Regions Covered

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bulk Liquids, Dry Bulk Materials, Forest Products, Refrigerated Goods)

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User (Healthcare Providers, Patients, Payers) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Medical Billing Outsourcing Global Market Report 2025 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Transthyretin Amyloidosis Treatment Market Definition

Transthyretin Amyloidosis Treatment Market Size

Transthyretin Amyloidosis Treatment Market Drivers

Transthyretin Amyloidosis Treatment Market Restraints

Transthyretin Amyloidosis Treatment Market Trends

Opportunities And Recommendations In The Transthyretin Amyloidosis Treatment Market

Transthyretin Amyloidosis Treatment Market Segmentation

Transthyretin Amyloidosis Treatment Market Competitive Landscape

Major Competitors are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

What Is The Biohacking Market Overview In 2022?

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bulk Liquids, Dry Bulk Materials, Forest Products, Refrigerated Goods)

Medical Billing Outsourcing Global Market Report 2025 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2025-2034

Frequently Asked Questions